We are a fully integrated biopharmaceutical company focused on the development and commercialization of therapeutics for patients with chronic kidney disease.
Copyright West LLC. Minimum 15 minutes delayed.
4:30 PM EDT
|Akebia’s Fourth Quarter and Fiscal Year 2018 Financial Results|
9:30 AM PST
|37th Annual J.P. Morgan Healthcare Conference|
|12/03/18||Global Mizuho Investor Conference|